- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/46 - SulfonesSulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
Patent holdings for IPC class C07C 317/46
Total number of patents in this class: 89
10-year publication summary
|
7
|
10
|
7
|
5
|
6
|
3
|
4
|
3
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2700 |
6 |
| NOVUS International, Inc. | 140 |
5 |
| Peloton Therapeutics, Inc. | 38 |
4 |
| University of Tennessee Research Foundation | 765 |
4 |
| Sanofi | 4326 |
4 |
| Bristol-myers Squibb Company | 4757 |
3 |
| Bayer AG | 3553 |
3 |
| Bayer Cropscience AG | 1830 |
3 |
| The Board of Regents of the University of Oklahoma | 663 |
3 |
| Kumiai Chemical Industry Co., Ltd. | 314 |
3 |
| OM Pharma | 41 |
3 |
| Sumitomo Chemical Company, Limited | 8965 |
2 |
| Laboratoire Medidom S.A. | 46 |
2 |
| Lead Pharma CEL Models IP B.V. | 2 |
2 |
| Medeia Therapeutics Ltd | 5 |
2 |
| Nihon Nohyaku Co., Ltd. | 327 |
2 |
| Lead Pharma Holding B.V. | 20 |
2 |
| Autobahn Therapeutics, Inc. | 45 |
2 |
| Immvention Therapeutix | 4 |
2 |
| F. Hoffmann-La Roche AG | 7798 |
1 |
| Other owners | 31 |